Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2021)

Assembly Biosciences' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $41.6 million for Q4 2021.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $41.6 million in Q4 2021; TTM through Sep 2022 was $41.6 million, a N/A change from a year earlier, with the FY2021 full-year figure at $41.6 million, changed N/A from the prior year.
• Other Operating Expenses grew to $41.6 million in Q4 2021 per ASMB's latest filing, from $4000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $41.6 million in Q4 2021 and bottomed at -$127000.0 in Q2 2018.
• The 4-year median for Other Operating Expenses is $4.5 (2017), against an average of $4.1 million.
• Across the five-year window, Other Operating Expenses tumbled 39713.53% in 2018 and surged 104.35% in 2019, its largest moves.
• Year by year, Other Operating Expenses stood at -$447.0 in 2017, then slumped by 18244.52% to -$82000.0 in 2018, then soared by 104.88% to $4000.0 in 2019, then soared by 1040850.0% to $41.6 million in 2021.
• Per Business Quant, the three latest ASMB Other Operating Expenses figures stand at $41.6 million (Q4 2021), $4000.0 (Q2 2019), and $1000.0 (Q1 2019).